
Research at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.
https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-managing-treatment-gaps-with-pcsk9-inhibitors





